NBT BANCORP INC. overview

COSMAX NBT Showcases Exclusive Materials and Formulations at SSW 2023, Strengthening its Presence in the U.S. Market PR Newswire SEONGNAM, South Korea, Oct. 23, 2023 Display microemulsion technology and plant-based formulation Various exclusive materials prepared for skin health, wrinkles, and even hair health SEONGNAM, South Korea , Oct. 23, 2023 /PRNewswire/ -- COSMAX NBT, a global leading supplements ODM (original development manufacturing) company, announced on Oct. 18 that it is...

Shareholder Alert: Ademi LLP investigates whether Salisbury Bancorp, Inc. has obtained a Fair Price in its Transaction with NBT PR Newswire MILWAUKEE, Dec. 5, 2022 MILWAUKEE , Dec. 5, 2022 /PRNewswire/ -- Ademi LLP is investigating Salisbury (Nasdaq: SAL) for possible breaches of fiduciary duty and other violations of law in its transaction with NBT. Click here to learn how to join the action https://www.ademilaw.com/case/salisbury-bancorp-inc or call Guri Ademi toll-free at 866-264-3995. There...

1000 times intestinal survival rate...COSMAX NBT commercializes 'Zeta Probiotics™' Technology PR Newswire SEONGNAM-SI, South Korea, June 9, 2022 - A technology restores the cell wall and surface charges of probiotics damaged by the freeze-drying process - 66.7% increase of intestinal adhesion…Have commercialized the products in May SEONGNAM-SI, South Korea , June 9, 2022 /PRNewswire/ -- COSMAX Group has succeeded in developing and commercializing a technology that dramatically increased the...

Company announcement, Helsinki, 5 December 2019 at 11.10 am (EET) Nexstim Plc: Health Canada Grants Nexstim NBT® Medical Device License for Canada Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada. The medical device license allows Nexstim to start marketing and commercial distribution of the NBT® system for the treatment of Major Depressive Disorder (MDD) in Canada. MDD is a recurrent...

Press Release, Helsinki, 2 December 2019 at 10 am (EET) Nexstim NBT® System with SmartFocus® TMS installed at Rockford Psychiatric Medical Services, US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Rockford Psychiatric Medical Services has started using Nexstim NBT® System with SmartFocus® TMS technology. Rockford Psychiatric Medical Services is a private psychiatric clinic located in Illinois, US. The clinic’s expertise covers a variety of psychiatric clinical...

Press Release, Helsinki, 17 October 2019 at 1.00pm (EEST) Nexstim has placed an NBT ® System to Epworth Clinic, Australia Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has placed an NBT® system with SmartFocus® technology to Epworth Clinic in Camberwell, Australia. Epworth Clinic is known for its world leading mental...

Press Release, Helsinki, 14 October 2019 at 3.00 pm (EET) Nexstim has placed an NBT® System with SmartFocus® technology to Stanford University Medical Center Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has placed an NBT® system with SmartFocus® TMS technology to Stanford University Medical Center, US. Stanford...